Geneva, 16 November 2021 – As part of a pledge of 3 million doses to COVAX by the Hellenic Republic, 376,800 doses of the AstraZeneca COVID-19 vaccine have arrived in Kenya and 144,000 in Syria. Greece’s donation is part of a broader Team Europe commitment to equitable access, with the European Commission and European countries working alongside COVAX to provide millions of doses to countries around the world.
Greece’s dose donation pledge comes on top of a previous funding commitment of EUR 1.5 million to support Gavi countries’ response to the COVID-19 pandemic; through Gavi’s COVAX Advance Market Commitment (Gavi COVAX AMC), made by Greece Prime Minister Kyriakos Mitsotakis during the Coronavirus Global Response Conference on April 4th. That new funding will support lower-income countries’ response to the COVID-19 pandemic, including supporting health systems.
“At this critical period in modern global history, the expression of solidarity is essential and a responsibility of all,” said Dr Mina Gaga, Greek Alternate Minister of Health. “Greece is committed to support, advocate and accelerate vaccination efforts for countries most in need. Greece has already pledged to share 3 million doses of COVID-19 vaccines with lower-income economies through the COVAX Facility and commits to further increase its contribution. It is with great pleasure that we witness our first donations through COVAX reach Syria & Kenya today. Humanity is facing an unprecedented challenge. We stand united.”
“I am exceedingly grateful to the Hellenic Republic for its commitment to equitable access to vaccines,” added Ms Marie-Ange Saraka-Yao, Gavi Managing Director for Resource Mobilisation, Private Sector Partnerships and Innovative Finance. “This first shipment, as part of a donation of 3 million doses and a pledge of EUR 1.5 million in funding, will mean more people are protected and we can move closer to ending the acute phase of the pandemic.”
These doses donated by Greece are produced by the AstraZeneca manufacturing network. Donating through COVAX helps to increase vaccine coverage, ensures that no dose goes to waste, and helps to bring an end to the acute phase of the pandemic. The design and operationalization of the COVAX dose sharing mechanism is being supported by a contribution of CAD 5 million from Canada.
The donation of doses via COVAX are enabled via tripartite agreements between Gavi, manufacturers, and donating countries. COVAX shipments to countries are enabled by delivery partners UNICEF and the Pan American Health Organisation (PAHO).
Over 1.3 billion doses have already been pledged to COVAX by a number of countries in response to short-term supply challenges and the rise of new variants. Working with donor governments to operationalise growing numbers of dose-sharing pledges, COVAX expects to see more deliveries of donated doses in the weeks and months to come.